A detailed history of Cambridge Trust CO transactions in Zoetis Inc. stock. As of the latest transaction made, Cambridge Trust CO holds 106,081 shares of ZTS stock, worth $18.8 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
106,081
Previous 79,054 34.19%
Holding current value
$18.8 Million
Previous $15.6 Million 15.04%
% of portfolio
0.69%
Previous 0.66%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 30, 2024

BUY
$165.67 - $199.94 $4.48 Million - $5.4 Million
27,027 Added 34.19%
106,081 $17.9 Million
Q4 2023

Jan 31, 2024

BUY
$151.44 - $200.09 $1.18 Million - $1.56 Million
7,772 Added 10.9%
79,054 $15.6 Million
Q3 2023

Oct 26, 2023

BUY
$167.14 - $192.77 $11.7 Million - $13.5 Million
69,880 Added 4984.31%
71,282 $12.4 Million
Q2 2023

Jul 25, 2023

BUY
$160.94 - $186.23 $16,415 - $18,995
102 Added 7.85%
1,402 $241,000
Q1 2023

May 12, 2023

BUY
$145.48 - $175.02 $3,927 - $4,725
27 Added 2.12%
1,300 $216,000
Q4 2022

Jan 09, 2023

BUY
$131.14 - $157.47 $37,506 - $45,036
286 Added 28.98%
1,273 $187,000
Q3 2022

Nov 07, 2022

SELL
$148.29 - $182.55 $7,414 - $9,127
-50 Reduced 4.82%
987 $147,000
Q2 2022

Aug 16, 2022

BUY
$155.97 - $200.09 $33,065 - $42,419
212 Added 25.7%
1,037 $178,000
Q1 2022

May 12, 2022

BUY
$181.39 - $234.03 $31,924 - $41,189
176 Added 27.12%
825 $156,000
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $125,704 - $160,322
649 New
649 $158,000
Q4 2020

Jan 27, 2021

SELL
$157.07 - $174.35 $260,736 - $289,421
-1,660 Closed
0 $0
Q2 2020

Aug 05, 2020

SELL
$111.92 - $142.53 $11,751 - $14,965
-105 Reduced 5.95%
1,660 $258,000
Q4 2019

Feb 04, 2020

SELL
$116.25 - $133.25 $1,162 - $1,332
-10 Reduced 0.56%
1,765 $234,000
Q3 2019

Nov 06, 2019

BUY
$112.57 - $128.43 $199,811 - $227,963
1,775 New
1,775 $221,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.